Adma Biologics (ADMA) Receivables (2012 - 2026)
Adma Biologics' Receivables was $169.22 million in Q3 2026, up 22.9% from $137.67 million a year earlier and up 22.4% from the prior quarter.
Powered by 
Analysis
Adma Biologics (ADMA) Receivables (2012 - 2026) Analysis & Trends
At the end of FY2025, Receivables at Adma Biologics came in at $158.43 million, up 216.9% from FY2024.
- Receivables has now increased for three consecutive years, with a five-year compound annual growth rate of 64.3% (FY2020 to FY2025).
- In earlier years, Receivables was $50 million in FY2024 (+82.3%), $27.42 million in FY2023 (+76.9%), $15.51 million in FY2022 (-45.7%) and $28.58 million in FY2021 (+115.9%).
- The Q3 2026 figure marks the highest quarterly Receivables in data going back to Q2 2012.
- Compared with a year earlier, Receivables has increased for nine straight quarters, with growth averaging 115.5% over the last eight quarters.
- The best year-over-year quarter for Receivables over five years was Q2 2025 (growth of 264.4%); the worst was Q4 2022 (a decline of 45.7%).
- Per Business Quant data, ADMA's Receivables in the three quarters before Q3 2026 was $138.23 million (Q2 2026), $135.86 million (Q1 2026) and $158.43 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 25.23 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 18.99 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 13.51 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 12.74 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 16.16 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 10.35 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 5.01 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 14.19 Bn |
| 10 | Adma Biologics | 2.87 Bn | 2.39 Bn | 99.92 Mn | 169.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 169.22 Mn |
| Jun 30, 2026 | 138.23 Mn |
| Mar 31, 2026 | 135.86 Mn |
| Dec 31, 2025 | 158.43 Mn |
| Sep 30, 2025 | 137.67 Mn |
| Jun 30, 2025 | 109.73 Mn |
| Mar 31, 2025 | 99.41 Mn |
| Dec 31, 2024 | 50.00 Mn |
| Sep 30, 2024 | 50.14 Mn |
| Jun 30, 2024 | 30.11 Mn |
| Mar 31, 2024 | 49.62 Mn |
| Dec 31, 2023 | 27.42 Mn |
| Sep 30, 2023 | 31.32 Mn |
| Jun 30, 2023 | 36.73 Mn |
| Mar 31, 2023 | 26.52 Mn |
| Dec 31, 2022 | 15.51 Mn |
| Sep 30, 2022 | 20.90 Mn |
| Jun 30, 2022 | 18.88 Mn |
| Mar 31, 2022 | 25.63 Mn |
| Dec 31, 2021 | 28.58 Mn |
API Access
Adma Biologics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=ADMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "ADMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=ADMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();